Department of Anesthesiology, Cancer Institute & Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Chin Med J (Engl). 2009 Oct 5;122(19):2330-4.
Although etomidate is associated with very few cardiovascular side-effects and minimal histamine release, it has a less inhibitory effect on the pharyngolaryngeal reflex. Hence, blunting the responses to endotracheal intubation is more dependent of opioids for etomidate-based anesthetic induction. This prospective, randomized, double-blinded study was designed to investigate the effects of low dose remifentanil, fentanyl or sufentanil on etomidate induction with respect to hemodynamics, conscious level changes and drug consumption.
Ninety unpremedicated and normotensive patients with American Society of Anesthesiologists (ASA) physical status I or II undergoing elective major abdominal surgery were randomly assigned in a double blinded fashion to each of the three groups: groups F, R and S. A bolus dose of fentanyl 1 microg/kg, sufentanil 0.1 microg/kg or remifentanil 1 microg/kg was given over 60 seconds in groups F, S and R, respectively. In each instance this loading dose was followed by a continuous infusion (0.1, 0.01 or 0.1 microg x kg(-1) x min(-1) of fentanyl, sufentanil or remifentanil, respectively). After 5 minutes from start of opioid infusion, etomidate was titrated at a rate of 20 mg/min to a decrease in bispectral index (BIS) to 50. The time from administration of etomidate to loss of eyelash reflex or to a decrease in BIS to 50 was recorded. The blood pressure and heart rate were also recorded at different five time points. The average maximum percent changes of systolic blood pressure (|maximal or minimal measuring value-baseline|/baseline x 100%) were calculated.
The time and the dosage of etomidate necessary to loss consciousness were greater in group F ((70.0 +/- 15.6) seconds; (0.35 +/- 0.05) mg/kg) than in groups S ((52.3 +/- 15.9) seconds; (0.26 +/- 0.06) mg/kg) and R ((56.2 +/- 20.2) seconds; (0.27 +/- 0.07) mg/kg) (P < 0.01). The three groups took similar time and amount of etomidate to achieve an adequate depth anesthesia (BIS = 50). The average maximum changes of systolic blood pressure were significantly different among the three groups: F, (25 +/- 6)% vs R, (13 +/- 4)% or S, (12 +/- 5)% (P < 0.001). The endotracheal intubation caused marked increases in blood pressure and heart rate in groups F and S, but not in group R, respectively (P < 0.01). The great hemodynamic changes occurred more frequently in group F than in groups R and S (P < 0.01). The incidence of heart rate decreases of more than 30% of the baselines after induction was higher in group R compared with groups F and S (P < 0.01).
In normotensive and unpremedicated young adult patients receiving etomidate induction, low dose remifentanil or sufentanil significantly reduced the time and the amount of etomidate taken to loss unconsciousness compared with low dose fentanyl, but similar time interval and doses of etomidate were required to acquire adequate depth of anesthesia (BIS = 50) for these three opioids. Remifentanil was more effective in blunting the cardiovascular responses to endotracheal intubation, nevertheless, accompanying significant lower heart rate after induction.
虽然依托咪酯与很少的心血管副作用和最小的组胺释放有关,但它对咽喉反射的抑制作用较小。因此,在依托咪酯诱导麻醉中,要使气管插管的反应变钝,更依赖于阿片类药物。本前瞻性、随机、双盲研究旨在探讨小剂量瑞芬太尼、芬太尼或舒芬太尼对依托咪酯诱导的影响,观察其对血流动力学、意识水平变化和药物消耗的影响。
90 例未服用镇静剂的、血压正常的美国麻醉师协会(ASA)I 或 II 级择期行大型腹部手术的患者,随机分为三组:F 组、R 组和 S 组。F 组、S 组和 R 组分别静脉给予芬太尼 1μg/kg、舒芬太尼 0.1μg/kg 或瑞芬太尼 1μg/kg,持续 60 秒。在每例患者中,该负荷剂量后给予持续输注(芬太尼、舒芬太尼或瑞芬太尼分别为 0.1、0.01 或 0.1μg·kg-1·min-1)。在阿片类药物输注开始后 5 分钟,以 20mg/min 的速度滴定依托咪酯,直至脑电双频指数(BIS)降至 50。记录从给予依托咪酯到睫毛反射消失或 BIS 降至 50 的时间。不同五个时间点记录血压和心率。计算收缩压的平均最大百分比变化(|最大或最小测量值-基线|/基线 x 100%)。
F 组(70.0±15.6)秒;(0.35±0.05)mg/kg 比 S 组(52.3±15.9)秒;(0.26±0.06)mg/kg 和 R 组(56.2±20.2)秒;(0.27±0.07)mg/kg )意识消失所需的依托咪酯时间和剂量更大(P<0.01)。三组达到足够深度麻醉(BIS=50)所需的依托咪酯时间和剂量相似。收缩压的平均最大变化在三组之间有显著差异:F 组为(25±6)%,R 组为(13±4)%,S 组为(12±5)%(P<0.001)。F 组和 S 组气管插管引起血压和心率明显升高,但 R 组无明显变化(P<0.01)。F 组较 R 组和 S 组更频繁发生严重的血液动力学变化(P<0.01)。诱导后心率下降超过基线 30%的发生率在 R 组高于 F 组和 S 组(P<0.01)。
在接受依托咪酯诱导麻醉的血压正常、未服用镇静剂的年轻成年患者中,与小剂量芬太尼相比,小剂量瑞芬太尼或舒芬太尼可显著减少意识消失所需的依托咪酯时间和剂量,但这三种阿片类药物达到足够深度麻醉(BIS=50)所需的依托咪酯时间和剂量相似。瑞芬太尼在减轻气管插管对心血管的反应方面更有效,但在诱导后心率明显下降。